New Zealand reports first death linked to Pfizer COVID-19 vaccine

Middle East
30-08-2021 | 04:33
High views
Share
LBCI
Share
LBCI
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
New Zealand reports first death linked to Pfizer COVID-19 vaccine
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
2min
New Zealand reports first death linked to Pfizer COVID-19 vaccine

New Zealand reported its first recorded death linked to U.S. drugmaker Pfizer's COVID-19 vaccine, the health ministry said on Monday, after a woman suffered a rare side effect leading to inflammation of her heart muscle.

The news of the death comes as the country battles an outbreak of the Delta variant after nearly six months of being virus free. It followed a review by an independent panel monitoring the safety of the vaccines.

"This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer COVID-19 vaccine," the ministry said in a statement, without giving the woman's age.

The vaccine monitoring panel attributed the death to myocarditis, a rare, but known, side effect of the Pfizer vaccine, the ministry added.

Myocarditis is an inflammation of the heart muscle that can limit the organ's ability to pump blood and can cause changes in heartbeat rhythms.

In response, Pfizer said it recognized there could be rare reports of myocarditis after vaccinations, but such side effects were extremely rare.

"Pfizer takes adverse events that are potentially associated with our vaccine very seriously," it told Reuters.

 
 
REUTERS
 

Breaking Headlines

New Zealand

Pfizer

Vaccine

Coronavirus

Covid19

Download now the LBCI mobile app
To see the latest news, the latest daily programs in Lebanon and the world
Google Play
App Store
We use
cookies
We use cookies to make
your experience on this
website better.
Accept
Learn More